News from ansun biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 08, 2018, 09:00 ET Ansun Biopharma Announces Key Appointments to its Executive Management Team

Ansun Biopharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat...


May 14, 2018, 09:00 ET Ansun BioPharma secures $85 million in Series A Financing

Ansun BioPharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat...


Oct 10, 2017, 09:00 ET Ansun BioPharma Announces Breakthrough Designation for its Experimental Drug DAS181

Today, Ansun BioPharma announced that the Division of Antiviral Products of the U.S. Food and Drug Administration (FDA) has granted Breakthrough...


Sep 27, 2016, 06:00 ET Ansun BioPharma Announces Two Publications Showing Inhibitory Effects of DAS181 on Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV)

Ansun BioPharma announced today the publication of two reports by researchers showing potent inhibitory effect of DAS181 on respiratory syncytial...


May 09, 2016, 06:00 ET Ansun BioPharma Named Buzz of BIO Winner for the 2016 BIO International Convention

On Thursday, the Biotechnology Innovation Organization (famously known as BIO) announced the Buzz of BIO winners for the 2016 BIO Convention to be...


Dec 08, 2015, 09:00 ET Ansun BioPharma Announces Potent in-vitro DAS181 Activity against Respiratory Syncytial Virus at 5th Congress of Virology

Ansun BioPharma announced preliminary data suggesting in-vitro activity of DAS181 against Respiratory Syncytial Virus (RSV), a virus which causes...


Oct 09, 2015, 06:00 ET Ansun BioPharma Announces Successful Treatment with DAS181 in A Patient with Severe Influenza and Parainfluenza at IDSA Meeting

Ansun BioPharma announced a presentation at IDSA's IDWeek 2015 meeting (Infectious Disease Society of America ) regarding the compassionate use of...


Sep 28, 2015, 06:00 ET Ansun BioPharma Announces CDC Publication Showing Potent Inhibitory Effects of DAS181 on Enterovirus68

Ansun BioPharma announced today the publication of a report by researchers at the Centers for Disease Control demonstrating the strong inhibition of...


Jul 27, 2015, 06:00 ET Investigation of Ansun Biopharma Dismissed, Company Continues Development of Therapies for Severe Respiratory Infections

Ansun BioPharma, Inc., a San Diego-based biotech company, is pleased to announce that an investigation by the United States Attorney's office over...


Jul 07, 2015, 06:00 ET Ansun BioPharma Publishes Effects of FluDase™ on Drug Resistant Flu

Ansun Biopharma announced today the publication of the report "Treatment of resistant influenza virus infection in a hospitalized patient with cystic ...